111 Inc (YI)
1.02
+0.01
(+0.99%)
USD |
NASDAQ |
Apr 26, 16:00
1.02
0.00 (0.00%)
After-Hours: 16:45
111 Cash from Financing (TTM): 31.47M for Sept. 30, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | 31.47M |
June 30, 2023 | 10.46M |
March 31, 2023 | 9.304M |
December 31, 2022 | 3.385M |
September 30, 2022 | 29.54M |
June 30, 2022 | 34.93M |
March 31, 2022 | 45.24M |
December 31, 2021 | 11.51M |
September 30, 2021 | 65.47M |
June 30, 2021 | 133.66M |
Date | Value |
---|---|
March 31, 2021 | 136.16M |
December 31, 2020 | 155.11M |
September 30, 2020 | 73.28M |
June 30, 2020 | 13.91M |
March 31, 2020 | 3.465M |
December 31, 2019 | 15.78M |
September 30, 2019 | 18.46M |
June 30, 2019 | 109.72M |
March 31, 2019 | 150.22M |
December 31, 2018 | 147.14M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
3.385M
Minimum
Dec 2022
155.11M
Maximum
Dec 2020
50.05M
Average
30.51M
Median
Cash from Financing (TTM) Benchmarks
Concord Medical Services Holdings Ltd | -- |
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | -- |
Zai Lab Ltd | -6.433M |
I-MAB | -- |